[go: up one dir, main page]

PE20130526A1 - Componentes de la pared de celulas de levadura y deteccion de los mismos - Google Patents

Componentes de la pared de celulas de levadura y deteccion de los mismos

Info

Publication number
PE20130526A1
PE20130526A1 PE2012002163A PE2012002163A PE20130526A1 PE 20130526 A1 PE20130526 A1 PE 20130526A1 PE 2012002163 A PE2012002163 A PE 2012002163A PE 2012002163 A PE2012002163 A PE 2012002163A PE 20130526 A1 PE20130526 A1 PE 20130526A1
Authority
PE
Peru
Prior art keywords
wall
primary antibody
antigen
detection
components
Prior art date
Application number
PE2012002163A
Other languages
English (en)
Inventor
Colm Moran
Stefan Kwiatkowski
Alexandros Yiannikouris
Ursula Anne Thielen
Original Assignee
Alltech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alltech Inc filed Critical Alltech Inc
Publication of PE20130526A1 publication Critical patent/PE20130526A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
    • G01N2333/395—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Saccharomyces
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
    • G01N2400/14—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar alpha-D-Glucans, i.e. having alpha 1,n (n=3,4,6) linkages between saccharide units, e.g. pullulan
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
    • G01N2400/24—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar beta-D-Glucans, i.e. having beta 1,n (n=3,4,6) linkages between saccharide units, e.g. xanthan

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE REFIERE A UN METODO QUE COMPRENDE: a) PROPORCIONAR UNA MUESTRA SELECIONADO DE MELAZA, FIBRAS, PASTO ENTRE OTROS; b) EXPONER LA MUESTRA A UN ANTICUERPO PRIMARIO CAPAZ DE UNIRSE A UN ANTIGENO SELECIONADO DEL GRUPO QUE CONSISTE DE (1 - 4)- ALFA-D-GLUCANO, ( 1-6)-BETA-D-GLUCANO, Y (1-4)- ALFA /(1-6)- BETA -D-GLUCANO DE ESTE MODO FORMANDO UN COMPLEJO DE ANTICUERPO-ANTIGENO PRIMARIO; c) DETECTAR EL GRADO DE ENLACE ENTRE EL ANTICUERPO PRIMARIO Y EL ANTIGENO USANDO UN ANTICUERPO SECUNDARIO EL CUAL ES CONJUGADO A UNA SUSTANCIA SELECCIONADA DE ENZIMAS, MATERIAL FLUOROGENICO, CROMOGENICO Y UN ISOTOPO RADIOETIQUETADO. DICHO PROCESO PROPORCIONA ANTICUERPOS CAPACES DE RECONOCER ANTIGENOS DE LA PARED DE CELULAS.
PE2012002163A 2010-05-14 2011-05-13 Componentes de la pared de celulas de levadura y deteccion de los mismos PE20130526A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33499510P 2010-05-14 2010-05-14

Publications (1)

Publication Number Publication Date
PE20130526A1 true PE20130526A1 (es) 2013-05-05

Family

ID=44912110

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012002163A PE20130526A1 (es) 2010-05-14 2011-05-13 Componentes de la pared de celulas de levadura y deteccion de los mismos

Country Status (26)

Country Link
US (1) US20110281283A1 (es)
EP (1) EP2569632B1 (es)
JP (1) JP2013532276A (es)
KR (1) KR101440818B1 (es)
CN (1) CN102939537B (es)
AU (1) AU2011252840B2 (es)
BR (1) BR112012030535B1 (es)
CA (1) CA2798328A1 (es)
CL (1) CL2012003165A1 (es)
CO (1) CO6660470A2 (es)
DK (1) DK2569632T3 (es)
EA (1) EA201291091A1 (es)
ES (1) ES2691260T3 (es)
IL (1) IL222789A (es)
MX (1) MX2012013170A (es)
MY (1) MY173081A (es)
NZ (2) NZ623714A (es)
PE (1) PE20130526A1 (es)
PH (1) PH12012502227A1 (es)
PL (1) PL2569632T3 (es)
PT (1) PT2569632T (es)
RS (1) RS57937B1 (es)
SG (1) SG185485A1 (es)
UA (1) UA103283C2 (es)
WO (1) WO2011143613A1 (es)
ZA (1) ZA201208200B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106103727A (zh) * 2014-03-21 2016-11-09 帝斯曼知识产权资产管理有限公司 用产生昆布五糖的β‑1,3‑葡聚糖酶处理酵母细胞壁的方法
EP3294750B1 (en) * 2015-05-08 2023-10-25 Waters Technologies Corporation Composition and methods for extracting mycotoxins
CN105137084B (zh) * 2015-08-20 2016-09-28 厦门大学 一种葡聚糖的夹心酶联免疫吸附测定方法
JP6530846B1 (ja) * 2018-10-09 2019-06-12 アサヒグループホールディングス株式会社 免疫賦活剤及び感染予防方法
CN114196216B (zh) * 2021-12-27 2023-01-06 杭州靡特洛新材料科技有限公司 一种基于酒糟废弃物的全生物降解热塑水溶膜及其制备方法和应用
CN117126753B (zh) * 2023-10-26 2024-04-09 中粮营养健康研究院有限公司 产多糖酿酒酵母及其在龙眼葡萄酒酿造中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0597960B1 (en) 1991-08-10 1999-01-20 Medical Research Council Treatment of cell populations
CA2150262C (en) 1992-12-04 2008-07-08 Kaspar-Philipp Holliger Multivalent and multispecific binding proteins, their manufacture and use
EP0664671B1 (en) * 1993-08-06 2002-09-11 Biotec Pharmacon ASA Animal feeds comprising yeast glucan
DE4402065A1 (de) * 1994-01-25 1995-09-07 Behringwerke Ag Saccharomyces-spezifische Antigene und Antikörper, deren Herstellung und Verwendung
US6214337B1 (en) * 1995-04-18 2001-04-10 Biotec Asa Animal feeds comprising yeast glucan
DE69832690T2 (de) * 1998-04-17 2006-07-13 Biotrex S.R.L. Produkt auf Basis von Polysacchariden aus Backhefe und seine Verwendung als Additiv fur Backwaren
EP1234886A1 (en) * 2001-02-23 2002-08-28 Universiteit van Amsterdam A method for detecting beta-1,6-glucan synthase activity
GB0211118D0 (en) * 2002-05-15 2002-06-26 Polonelli Luciano Vaccines
DE602004022325D1 (de) * 2003-10-31 2009-09-10 Immunetics Inc Der kontamination von blutplättchen mit bakterien
US20050020490A1 (en) * 2004-10-18 2005-01-27 Progressive Bioactives Incorporated A Method of Producing an Economical and Ecologically Sound Natural Immunobiotic Extract for Use as a Health Management Instrument and a Replacement for Growth Promotion Antibiotics in Livestock and Companion Animals.
US20080102486A1 (en) * 2006-10-27 2008-05-01 Horgan Karina A Method for detection of yeast cell wall
US8933133B2 (en) * 2006-12-14 2015-01-13 Adm Alliance Nutrition, Inc. Animal feeds containing polyols
JP5054425B2 (ja) * 2007-05-07 2012-10-24 尚仁 大野 抗β−１，６−グルカン・モノクローナル抗体
CN101353383B (zh) * 2008-09-17 2010-12-08 山东京博控股发展有限公司 水溶性酵母β-葡聚糖及其制备方法
CN101403749B (zh) * 2008-11-17 2012-11-07 北京大学 通过葡聚糖特异性抗体辅助诊断自身免疫性疾病的试剂盒

Also Published As

Publication number Publication date
BR112012030535A2 (pt) 2018-01-16
RS57937B1 (sr) 2019-01-31
UA103283C2 (ru) 2013-09-25
DK2569632T3 (en) 2018-11-19
ES2691260T3 (es) 2018-11-26
ZA201208200B (en) 2014-01-29
PH12012502227A1 (en) 2021-06-23
NZ623714A (en) 2015-10-30
US20110281283A1 (en) 2011-11-17
CA2798328A1 (en) 2011-11-17
CN102939537A (zh) 2013-02-20
EA201291091A1 (ru) 2013-05-30
PL2569632T3 (pl) 2019-02-28
MX2012013170A (es) 2013-01-17
BR112012030535B1 (pt) 2021-06-01
IL222789A (en) 2016-09-29
CL2012003165A1 (es) 2013-09-23
EP2569632A4 (en) 2014-01-08
WO2011143613A1 (en) 2011-11-17
JP2013532276A (ja) 2013-08-15
SG185485A1 (en) 2012-12-28
CO6660470A2 (es) 2013-04-30
EP2569632B1 (en) 2018-08-15
KR101440818B1 (ko) 2014-11-03
NZ603340A (en) 2014-04-30
PT2569632T (pt) 2018-11-20
IL222789A0 (en) 2012-12-31
MY173081A (en) 2019-12-25
AU2011252840B2 (en) 2014-07-03
KR20130038863A (ko) 2013-04-18
CN102939537B (zh) 2016-09-14
EP2569632A1 (en) 2013-03-20

Similar Documents

Publication Publication Date Title
PE20130526A1 (es) Componentes de la pared de celulas de levadura y deteccion de los mismos
ECSP088081A (es) Detección de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapéutico correspondiente
MX362075B (es) Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo.
PE20180950A1 (es) Anticuerpos biespecificos especificos para un receptor de tnf coestimulador
EA201100668A1 (ru) Способы продуцирования антител из плазматических клеток
EA201400875A1 (ru) Антитела к cd47 и способы их применения
ATE528648T1 (de) Verfahren zum nachweis antikörper-herstellender zellen
TR201900160T4 (tr) Bir anti-ilaç antikoru varlığının veya miktarının saptanmasına yönelik analizler.
MX2015012825A (es) Anticuerpos monoclonales del dominio de union de lipido del núcleo del virus de la hepatitis c vhc.
MX2019008970A (es) Ensayos de socio de unión específico de plasmón basados en solución y nanoestructuras metálicas.
AR098126A1 (es) Anticuerpos anti-ly6e (locus e del complejo del antígeno 6 linfocítico), inmunoconjugados y métodos para usarlos
EA201791610A1 (ru) Проникающие в клетку антитела
WO2008073895A3 (en) Methods and devices for testing saliva
MX2017009485A (es) Detección y aislamiento de células fetales basadas en microfluidos para prueba prenatal no invasiva.
PE20220004A1 (es) Anticuerpos monoclonales especificos para el antigeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por vrsh
RU2015104737A (ru) Способ обнаружения мультиспецифического связывающего агента
RU2016145600A (ru) Комбинированный продукт для детекции маркера-мишени
BR112018073660A2 (pt) anticorpos anti-fator ix pádua
AR087654A1 (es) METODO DIAGNOSTICO DE ANIMALES VACUNADOS CON PESTIVIRUS QUIMERICO EN EL CUAL LA PROTEINA Eʳⁿˢ DEL VIRUS DE LA DIARREA VIRAL BOVINA (BVDV) ES REMPLAZADA POR PROTEINA Eʳⁿˢ DE PESTIVIRUS DE ANTILOPE AMERICANO
ATE496300T1 (de) Immuntestverfahren und -chip
AR117546A1 (es) Anticuerpos monoclonales específicos para el antígeno pb2 del virus de la influenza humana (flu), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por flu
MX2018015047A (es) Metodo para la deteccion de un anticuerpo igm especifico para un flavivirus en una muestra.
EA201400571A1 (ru) Специфичные к трансресвератролу антитела и их применение
CL2009000768A1 (es) Metodo para identificar polipeptidos que comprenden un determinante antigenico de reaccion cruzada que comprende las etapas de obtener un anticuerpo de un animal expuesto secuencialmente a dos desafios con dos polipeptidos con determinantes antigenicos de una misma especie, pero distinto serotipo.
WO2008120006A3 (en) Diagnostic assay

Legal Events

Date Code Title Description
FC Refusal